Back to today’s briefing

Story perspectives

Attorneys General Demand FDA Action on Counterfeit Weight Loss Drugs

4/2/2025

29 3

Summary

Story summary

In a powerful call to action, over 30 state attorneys general are urging the FDA to tackle the rising threat of counterfeit weight loss drugs as shortages of popular medications like Ozempic and Mounjaro persist. With illegal online sales jeopardizing safety and some compound pharmacies potentially cutting corners, the FDA's recent announcement of an end to shortages adds further complexity to this urgent issue.

1 of 1

Story summary

In a powerful call to action, over 30 state attorneys general are urging the FDA to tackle the rising threat of counterfeit weight loss drugs as shortages of popular medications like Ozempic and Mounjaro persist. With illegal online sales jeopardizing safety and some compound pharmacies potentially cutting corners, the FDA's recent announcement of an end to shortages adds further complexity to this urgent issue.